Atrás
Rango del Día
$122.87
$125.22
Rango de 52 Semanas
$103.23
$164.28
Volumen
293,766
Promedio 50D / 200D
$131.85
/
$134.94
Cierre Anterior
$124.14
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 20.7 | 0.3 |
| P/B | 3.1 | 2.9 |
| ROE % | 15.3 | 3.7 |
| Net Margin % | 10.4 | 3.8 |
| Rev Growth 5Y % | 4.0 | 10.0 |
| D/E | 0.6 | 0.2 |
Precio Objetivo de Analistas
Hold
$169.67
+36.7%
Low: $133.00
High: $220.00
P/E Futuro
22.2
EPS Futuro
$5.59
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
3.9 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
$7.23
$6.90 – $7.55
|
4.4 B | 2 |
| FY2027 |
$6.49
$5.92 – $6.92
|
4.1 B | 6 |
| FY2026 |
$5.59
$5.40 – $5.68
|
3.9 B | 6 |
Puntos Clave
Revenue grew 4.01% annually over 5 years — modest growth
ROE of 15.28% — decent returns on equity
Generating 299.58M in free cash flow
Capital efficient — spends only 7.16% of revenue on capex
Crecimiento
Revenue Growth (5Y)
4.01%
Revenue (1Y)5.42%
Earnings (1Y)4.87%
FCF Growth (3Y)8.00%
Calidad
Return on Equity
15.28%
ROIC9.12%
Net Margin10.40%
Op. Margin13.53%
Seguridad
Debt / Equity
0.57
Current Ratio1.62
Interest Coverage9.69
Valoración
P/E Ratio
20.74
P/B Ratio3.05
EV/EBITDA18.16
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.42% | Revenue Growth (3Y) | 4.07% |
| Earnings Growth (1Y) | 4.87% | Earnings Growth (3Y) | 17.50% |
| Revenue Growth (5Y) | 4.01% | Earnings Growth (5Y) | 12.63% |
| Profitability | |||
| Revenue (TTM) | 3.78B | Net Income (TTM) | 392.79M |
| ROE | 15.28% | ROA | 7.48% |
| Gross Margin | 29.58% | Operating Margin | 13.53% |
| Net Margin | 10.40% | Free Cash Flow (TTM) | 299.58M |
| ROIC | 9.12% | FCF Growth (3Y) | 8.00% |
| Safety | |||
| Debt / Equity | 0.57 | Current Ratio | 1.62 |
| Interest Coverage | 9.69 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 20.74 | P/B Ratio | 3.05 |
| P/S Ratio | 2.16 | PEG Ratio | 3.60 |
| EV/EBITDA | 18.16 | Dividend Yield | 0.02% |
| Market Cap | 8.15B | Enterprise Value | 9.28B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.78B | 3.58B | 3.49B | 3.32B | 3.23B |
| Net Income | 392.79M | 374.54M | 284.49M | 239.29M | 244.10M |
| EPS (Diluted) | 5.89 | 5.53 | 4.25 | 3.59 | 3.60 |
| Gross Profit | 1.12B | 1.36B | 1.26B | 1.16B | 1.16B |
| Operating Income | 510.88M | 496.50M | 404.02M | 379.27M | 347.35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.25B | 4.43B | 4.45B | 4.20B | 4.14B |
| Total Liabilities | 2.54B | 1.95B | 2.13B | 2.14B | 2.16B |
| Shareholders' Equity | 2.67B | 2.47B | 2.31B | 2.05B | 1.97B |
| Total Debt | 1.53B | 1.08B | 1.18B | 1.22B | 1.24B |
| Cash & Equivalents | 402.42M | 223.84M | 223.64M | 141.73M | 122.93M |
| Current Assets | 1.89B | 1.48B | 1.55B | 1.43B | 1.36B |
| Current Liabilities | 1.17B | 1.07B | 1.25B | 917.18M | 982.49M |